Cargando…

The calcium sensitizer levosimendan reduces the brain natriuretic peptide levels as compared with dobutamine in intensive care unit septic patients with decompensated heart failure

Detalles Bibliográficos
Autores principales:	Michalopoulou, H, Stamatis, P, Bakhal, A, Kelgiorgis, T, Foundouli, A, Basile, A, Vaitsis, J, Reinou, E, Batika, P, Pragastis, D
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2007
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4095276/ http://dx.doi.org/10.1186/cc5382

Ejemplares similares

Identification of contractility abnormalities in intensive care unit patients with sepsis using tissue Doppler imaging
por: Michalopoulou, H, et al.
Publicado: (2007)

Incremental power of the combination of brain natriuretic peptide and tumoral antigen carbohydrate 125 for risk stratification in patients with acute heart failure
por: Michalopoulou, H, et al.
Publicado: (2008)

Renal insufficiency is a powerful predictor of worse outcome in patients with acute heart failure
por: Michalopoulou, H, et al.
Publicado: (2008)

Levosimendan Plus Dobutamine in Acute Decompensated Heart Failure Refractory to Dobutamine
por: Juguet, William, et al.
Publicado: (2020)

Use of levosimendan in myocardial dysfunction due to sepsis
por: Vaitsis, J, et al.
Publicado: (2009)

Levosimendan versus dobutamine in septic shock
por: Alhashemi, JA, et al.
Publicado: (2009)

Diastolic function abnormalities in ICU patients with chronic obstructive pulmonary disease
por: Michalopoulou, H, et al.
Publicado: (2008)

Role of inflammation in nonhemorrhagic strokes
por: Michalopoulou, H, et al.
Publicado: (2008)

Hyponatremia is associated with increased mortality in patients with acute decompensated hear failure
por: Vaitsis, J, et al.
Publicado: (2009)

Intravenous levosimendan vs. dobutamine in acute decompensated heart failure patients on beta-blockers
por: Bergh, Claes-Håkan, et al.
Publicado: (2010)

Circulating levels of tumor necrosis factor alpha, brain natriuretic peptide and cardiac Troponin I upon admission and 31-day mortality in patients with acute decompensated chronic heart failure
por: Zairis, P Batika, et al.
Publicado: (2007)

Levosimendan versus dobutamine in cardiac surgery
por: Delgado-Amaya, MD, et al.
Publicado: (2015)

Levosimendan versus dobutamine in Tako-tsubo cardiomyopathy
por: Righetti, FR, et al.
Publicado: (2013)

Levosimendan Versus Dobutamine in Myocardial Injury Patients with Septic Shock: A Randomized Controlled Trial
por: Meng, Jian-biao, et al.
Publicado: (2016)

Ischemia-modified albumin levels in patients with acute decompensated heart failure treated with dobutamine or levosimendan: IMA-HF study
por: Çavuşoğlu, Yüksel, et al.
Publicado: (2016)

The effects of levosimendan and dobutamine in experimental bupivacaine-induced cardiotoxicity
por: Kandemir, Ulku, et al.
Publicado: (2013)

Levosimendan, milrinone, and dobutamine in experimental acute pulmonary embolism
por: Lyhne, Mads D., et al.
Publicado: (2021)

Clinical outcomes of levosimendan versus dobutamine in patients with acute decompensated heart failure with reduced ejection fraction and impaired renal function
por: John, Basil, et al.
Publicado: (2021)

Relationship between B-type natriuretic peptide plasma levels and echocardiography parameters in decompensated chronic heart failure patients treated with levosimendan
por: Ferri, MB, et al.
Publicado: (2006)

N-terminal pro-brain natriuretic peptide as a prognostic marker in patients with exacerbation of chronic obstructive pulmonary disease
por: Stamatis, P, et al.
Publicado: (2013)

Combined effects of ivabradine with dobutamine or levosimendan in isolated perfused hearts
por: Konrad, D, et al.
Publicado: (2013)

Effect of correction of anemia in severe congestive heart failure
por: Michalopoulou, H, et al.
Publicado: (2009)

Levosimendan benefits critically ill patients with decompensated heart failure assessed with plasma B-type natriuretic peptide (BNP) and LVEF
por: McLean, AS, et al.
Publicado: (2003)

Comparative effects of recombinant human brain natriuretic peptide and dobutamine on acute decompensated heart failure patients with differsent blood BNP levels
por: Pan, Hai-Yan, et al.
Publicado: (2014)

Influence of temperature on the cardiac action of dobutamine and levosimendan in isolated perfused hearts
por: Aldenhoff, U, et al.
Publicado: (2013)

Levosimendan use in the emergency management of decompensated peripartum cardiomyopathy
por: Uriarte-Rodríguez, Alina, et al.
Publicado: (2010)

Newer treatments for decompensated heart failure: focus on levosimendan
por: Follath, Ferenc
Publicado: (2009)

Efficacy and safety of levosimendan and dobutamine in heart failure: A systematic review and meta-analysis
por: Jaguszewski, Milosz J., et al.
Publicado: (2021)

Effects of simultaneously infused terlipressin and dobutamine in septic shock
por: Morelli, A, et al.
Publicado: (2007)

Effect of levosimendan combined with recombinant human brain natriuretic peptide on diuretic resistance
por: Xiangli, Shen, et al.
Publicado: (2021)

Effects of levosimendan and inhaled nitric oxide on microcirculation in septic shock
por: Morelli, A, et al.
Publicado: (2009)

Effect of β-blockade on the haemodynamic responses of levosimendan and dobutamine in the treatment of low-output heart failure
por: Follath, F, et al.
Publicado: (2002)

Levosimendan versus dobutamine for sepsis-induced cardiac dysfunction: a systematic review and meta-analysis
por: Liu, Dong-Hua, et al.
Publicado: (2021)

Determinants of natriuretic peptides in early septic shock
por: Witthaut, R, et al.
Publicado: (1998)

Levosimendan in the Treatment of Patients with Severe Septic Cardiomyopathy
por: Tsolaki, Vasiliki, et al.
Publicado: (2023)

Treatment of calcium channel blocker overdose with levosimendan
por: Sencan, A, et al.
Publicado: (2011)

Comparison of dobutamine and levosimendan for treatment of sepsis-induced cardiac dysfunction: A protocol for systematic review and meta-analysis
por: Guo, Jun, et al.
Publicado: (2022)

Effects of levosimendan on renal function in septic shock: a case–control study
por: Morelli, A, et al.
Publicado: (2009)

Effects of epinephrine compared to dobutamine-norepinephrine on gastric perfusion in septic shock
por: Seguin, P, et al.
Publicado: (2002)

Study design of a mortality trial with intravenous levosimendan (the SURVIVE study) in patients with acutely decompensated heart failure
por: Mebazaa, A, et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_o4l9jv3arul8ca5gs2198ntf3f